PE Tech Report


Like this article?

Sign up to our free newsletter

Sheridan Capital Partners completes majority recapitalisation of SpendMend

Sheridan Capital Partners (Sheridan) has completed the majority recapitalisation of SpendMend in partnership with management and Morgan Stanley Capital Partners (MSCP), the middle-market focused private equity team at Morgan Stanley Investment Management.

Sheridan originally invested in SpendMend in January 2018 and enjoyed four successful years working closely with the founders. Co-founder and CEO Dan Geelhoed and co-founder and President Rob Heminger will continue to lead the business, while Sheridan has retained a minority ownership stake and board seat.
SpendMend is a provider of tech-enabled solutions to optimise the cost cycle for the US healthcare industry, and serves more than a third of the top 100 health systems.

Like this article? Sign up to our free newsletter